Characterization of the interaction between Trypanosoma brucei Pex5p and its receptor Pex14p

Yuichi Watanabe1, Kosuke Kawaguchi1, Naoki Okuyama1

  • 1Department of Biological Chemistry, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Sugitani, Japan.

FEBS Letters
|January 15, 2016
PubMed

Insights

The interaction between Trypanosoma brucei Pex5p and TbPex14p is key for protein transport into glycosomes. Specific motifs and charged amino acids mediate this crucial interaction for potential anti-trypanosomal drug development.

Area of Science:

  • Molecular Biology
  • Parasitology
  • Drug Discovery

Background:

  • The interaction between Trypanosoma brucei (Tb) Pex5p and its receptor TbPex14p is critical for protein import into the glycosome.
  • Glycosomal protein translocation is essential for the survival and proliferation of the parasite.

Purpose of the Study:

  • To elucidate the specific molecular interactions between TbPex5p and TbPex14p.
  • To identify the key motifs and amino acid residues involved in this protein-protein interaction.
  • To provide insights for the development of novel anti-trypanosomal therapeutic strategies.

Main Methods:

  • Analysis of the third WXXXF/Y motif of TbPex5p.
  • Investigation of the role of charged amino acids within the motif.
  • Structural modeling to predict interactions between TbPex5p and TbPex14p.

Main Results:

  • Only the third WXXXF/Y motif of TbPex5p is essential for binding to TbPex14p.
  • A negative charge at the fourth position of the motif is crucial for the interaction.
  • Specific phenylalanine and tryptophan residues in TbPex14p interact with the third motif, with adjacent lysine potentially binding the charged amino acid.

Conclusions:

  • The study precisely defines the interaction interface between TbPex5p and TbPex14p.
  • Understanding these molecular details is vital for designing drugs targeting glycosomal protein import in Trypanosoma brucei.
  • This knowledge facilitates the development of new anti-parasitic agents against African trypanosomiasis.